Patents Examined by Scott M. Getzow
  • Patent number: 11027126
    Abstract: Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one renewable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to block conduction in the nervous tissue. Delivering the first direct current can place the nervous tissue in a hypersuppressed state at least partially preventing conduction of the nervous tissue after cessation of delivering of the first direct current. The nervous tissue can be maintained in the hypersuppressed state for a desired period, such as at least about 1 minute.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: June 8, 2021
    Assignee: Presidio Medical, Inc.
    Inventors: Douglas Michael Ackermann, Kenneth Wu
  • Patent number: 11020587
    Abstract: A distal electrode of an electrode assembly, for example, employed by an implantable medical electrical lead device, extends distally from a distal terminal end of a sleeve of the assembly; and the sleeve, which defines a longitudinal axis of the assembly, includes a plurality of channels that provide fluid communication between a steroid eluting component, which is seated in an external groove of the sleeve, and an area distal to the distal terminal end of the sleeve. Floors of some or all of the sleeve channels may angle toward the longitudinal axis of the assembly, being closer to the axis at the distal terminal end of the sleeve. The assembly may further include a proximal electrode secured to a proximal end of the sleeve, wherein the proximal electrode may be mounted around an outer surface of the sleeve or coupled to the sleeve by means of a coupling component.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: June 1, 2021
    Assignee: Medtronic, Inc.
    Inventors: William J. Clemens, Linda L. Franke, Mark T. Marshall, Timothy M. Ramos, Vania Lee
  • Patent number: 11020598
    Abstract: Methods and devices for tying management of an implantable medical device to the activities of a primary care physician are described, including access control, simplified parameter optimization, support for tuning a device in response to the effects of other treatments in parallel, and support for helping a primary physician and a patient work together to tune device configuration to the activity and performance needs of the patient. In some embodiments, a medical device is self-configuring in a device parameter domain, based on inputs provided in a patient performance domain. The self-configuring of the medical device is based, for example, on an automatically applied transformation of inputs derived from patient performance domain observations into changes in the configuration of the medical device which affect technical parameters of its operation.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: June 1, 2021
    Assignee: Impulse Dynamics NV
    Inventors: Shlomo Ben-Haim, David Prutchi, Yuval Ben-Haim
  • Patent number: 11020602
    Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: June 1, 2021
    Assignee: CAMERON HEALTH, INC.
    Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
  • Patent number: 10993666
    Abstract: A cardiac electrophysiology system including a means for identifying the source of an arrhythmia in the heart is disclosed. The disclosed system may be an electrocardiograph device and may generate an enhanced electrocardiogram (EKG) of a cardiac structure. The disclosed system may include a disclosed catheter inserted into a chamber of the cardiac structure. The disclosed catheter may include electrodes configured to measure an analog electrical signal of the electrical activity of the cardiac structure over time, and a transformer configured to remove a direct current (DC) offset of the analog electrical signal to generate an analog electrical signal centered at 0 volts (V), which may be sampled by an analog-to-digital converter (ADC) and gain adjusted to a maximum resolution of the ADC to produce an enhanced digital electrocardiogram (EKG) signal.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: May 4, 2021
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Assaf Govari, Vadim Gliner
  • Patent number: 10994145
    Abstract: An implantable cardiac monitor (ICM) may be configured to be deployed subcutaneous, submuscular, or substernal at a position that enables the ICM to detect cardiac activity. In some cases, the ICM includes a housing that includes a body portion and a tail portion. A first electrode may be disposed adjacent a first end of the body portion, a second electrode may be disposed adjacent a second end of the body portion and a third electrode may be disposed adjacent a tail end of the tail portion. A controller may be disposed within the housing and may be operably coupled to the first electrode, the second electrode and the third electrode. The controller may be configured to select a pair of the first electrode, the second electrode and the third electrode to use for sensing cardiac electrical activity and to communicate information about the sensed activity to a second medical device.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: May 4, 2021
    Inventors: Brendan Early Koop, Lance Eric Juffer, Michael J. Kane, Benjamin J. Haasl, Keith R. Maile, Arthur J. Foster
  • Patent number: 10988034
    Abstract: An implantable device for deployment inside a human or animal body, the device comprising at least one sensing component arranged to respond to an electrical signal having a known frequency band and at least one antenna comprising at least one antenna pole connected to the at least one sensing component, the antenna pole comprising at least one helical coil and a connecting stem.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: April 27, 2021
    Inventors: Mohammad Reza Bahmanyar, Christopher Neil McLeod, Olive H Murphy
  • Patent number: 10981002
    Abstract: An implantable medical device that can include a main body having a tissue-contacting surface comprising a first edge and a second edge, an elongated shaft coupled at or near a first edge of the main body, and an anchoring feature extending from a second end of the elongated shaft. The elongated shaft can have a long axis that extends from a first end of the elongated shaft to a second end of the elongated shaft. The elongated shaft can be oriented such that the second end is positioned above the tissue-contacting surface and an angle between the long axis of the elongated shaft and the tissue-contacting surface is an acute angle. The device can further include an opposing elongated shaft coupled at or near a second edge of the main body.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: April 20, 2021
    Assignee: Verily Life Sciences LLC
    Inventor: Ken Rys
  • Patent number: 10981005
    Abstract: Neurostimulation assemblies, systems, and methods make possible the providing of short-term therapy or diagnostic testing by providing electrical connections between muscles and/or nerves inside the body and stimulus generators and/or recording instruments mounted on the surface of the skin or carried outside the body. The assembly affords maximum patient mobility and comfort through differentiated components having minimal profiles and connected by way of detachable and adjustable connections.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: April 20, 2021
    Inventors: Joseph W. Boggs, II, Robert B. Strother, Kathryn W. Stager, Jonathan L. Sakai, Amorn Wongsarnpigoon, Matthew deBock, Devin Sell, Meredith McGee
  • Patent number: 10973429
    Abstract: Certain aspects of the present disclosure provide methods and apparatus for determining a precise localization of an arrhythmia origin or exit site in a heart of a subject using internal electrocardiograph (ECG) signals sensed and stored by an implantable device implanted in the subject. One example method of analyzing an arrhythmia in a subject generally includes reading, from an implantable device implanted in the subject, a plurality of internal ECG signals sensed and stored by the implantable device while the subject was experiencing an arrhythmia event (e.g., at any time, including while the subject was ambulatory); performing an analysis of the read internal ECG signals; and determining a localization of the arrhythmia associated with the arrhythmia event, based on the analysis.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: April 13, 2021
    Assignee: Chelak iECG, Inc.
    Inventors: Jie Cheng, Dhanunjaya Lakkireddy
  • Patent number: 10967193
    Abstract: An external defibrillator system such as a WCD is also capable of providing transthoracic pacing and drug delivery (e.g., pain-reducing drugs and/or a sedatives) to a patient. The drug(s) may be included in the therapy electrode electrolyte and dispensed for defibrillation, cardioversion and/or pacing therapy. Alternatively, the drug(s) may be stored in a separate reservoir and dispensed during pacing therapy. The drug(s) may be dispensed to a patient after a successful defibrillation therapy. The pacing therapy may be delivered a set time-period after the drug(s) were dispensed. A relatively small electric current may be delivered to the area of the patient on which the drug(s) were dispensed to facilitate drug absorption.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: April 6, 2021
    Assignee: West Affum Holdings Corp.
    Inventor: Joseph L. Sullivan
  • Patent number: 10960210
    Abstract: An Example of a system for providing a patient with pain management may include a sleep monitoring circuit, a pain relief device, and a control circuit. The sleep monitoring circuit may be configured to sense one or more sleep signals from the patient and to determine a sleep state of the patient using the one or more sleep signals. The one or more sleep signals may include one or more physiological signals corresponding to the sleep state of the patient. The pain relief device may be configured to deliver one or more pain relief therapies. The control circuit may be configured to control the delivery of the one or more pain relief therapies using therapy parameters and to adjust the therapy parameters based on the determined sleep state.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: March 30, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kyle Harish Srivastava, Bryan Allen Clark, Elizabeth Mary Annoni, Jianwen Gu
  • Patent number: 10946197
    Abstract: Methods are provided for treating a subject for a condition by modulating at least a portion of the subject's autonomic nervous system. In accordance with certain embodiments of the subject methods, at least a portion of a subject's autonomic nervous system is electrically or pharmacologically modulated in a manner that is effective to treat the subject for the condition. The subject methods find use in the treatment of a variety of different conditions, where such conditions include various disease conditions. Also provided are systems and kits for use in practicing the subject methods.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: March 16, 2021
    Assignee: Palo Alto Investors
    Inventors: Anthony Joonkyoo Yun, Patrick Yuarn-Bor Lee
  • Patent number: 10918871
    Abstract: Systems and methods are provided for neuro stimulation. In one implementation, a system is provided that includes a stimulator introduced into tissue at a target location and a central controller that communicates wirelessly with the stimulator. The stimulator includes a power system that receives wireless energy transmission, and an electrode system that transmits an electrical pulse for stimulating the target location. The central controller includes a power system that wirelessly delivers power to the stimulator, a communication system that wirelessly communicates with the stimulator, and a processing system that controls the power system and the communication system. The central controller may instruct the stimulator to transmit one or more electrical pulses to the target location to affect an endocrine function (e.g., affect the glucose level of a patient).
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: February 16, 2021
    Inventors: Anil Kumar Ram Rakhyani, Peng Cong, Stephen O'Driscoll, Sean Korhummel, Travis Deyle
  • Patent number: 10918864
    Abstract: Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: February 16, 2021
    Assignee: Oculeve, Inc.
    Inventors: Manfred Franke, Diane Michelle Senchyna, Daniel N. Hamilton
  • Patent number: 10912472
    Abstract: A computer implemented method and system for identifying one or more areas of the heart muscle responsible for supporting or initiating abnormal heart rhythms using electrogram data recorded from a plurality of electrodes obtained from a corresponding series of sensing locations on the heart over a recording time period; the method including the steps of: setting a pre-defined geodesic distance, dividing the recording time period into several analysis time periods, and pairing each sensing location with a plurality of other sensing locations from within the defined geodesic distance, thus forming a plurality of location pairings; for each of the analysis time periods, defining the relative timing of each activation signal for each location within each pairing, determining whether the relative timing of activation signals falls within plausible biological parameters, defining the leading signal of the pair for each electrogram activation within the respective analysis time period; and assigning a series of lea
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: February 9, 2021
    Inventors: Malcolm Finlay, Shohreh Honarbakhsh, Richard Schilling, Ross Hunter, Waqas Ullah
  • Patent number: 10905328
    Abstract: Systems and methods are provided for continuously monitoring a user to determine when cardiovascular events are likely occurring and to responsively provide a prompt to a user to engage in additional physiological assessment of the putative cardiovascular event. Additional assessment can include the user engaging an additional sensor to provide signals that are more accurate, lower noise, or otherwise improved relative to a continuously-monitoring sensor used to initially detect the cardiovascular event. Detection of cardiovascular events includes using a cardiovascular classifier to determine, based on the output of such a continuously-monitoring sensor, whether the event is likely occurring. Such a classifier can be received from a cloud computing service or other remote system based on sensor outputs sent to such a system.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: February 2, 2021
    Assignee: Verily Life Sciences LLC
    Inventors: Mark Murphy, Nikhil Bikhchandani
  • Patent number: 10905882
    Abstract: A system and method for optimizing parameters of a DBS pulse signal for treatment of a patient is provided. In predicting optimal DBS parameters, functional brain data is input into a predictor system, the functional brain data acquired responsive to a sweeping across a multi-dimensional parameter space of one or more DBS parameters. Statistical metrics of brain response are extracted from the functional brain data for one or more ROIs or voxels of the brain via the predictor system, and a DBS functional atlas is accessed, via the predictor system, that comprises disease-specific brain response maps derived from DBS treatment at optimal DBS parameter settings for a plurality of diseases or neurological conditions. One or more optimal DBS parameters are predicted for the patient based on the statistical metrics of brain response and the DBS functional atlas via the predictor system.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: February 2, 2021
    Assignees: General Electric Company, University Health Network
    Inventors: Radhika Madhavan, Alexandre Boutet, Suresh Joel, Ileana Hancu, Jeffrey Ashe, Andres M. Lozano
  • Patent number: 10904675
    Abstract: There is disclosed a hearing prosthesis comprising a first housing containing a primary signal processor that receives signals output by a microphone; and a second housing removably connectable to the first housing; wherein a user interface is provided on the second housing that provides control of one or more features of the operation of the primary signal processor.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: January 26, 2021
    Assignee: Cochlear Limited
    Inventors: Gunther Van Der Borght, Jan Janssen
  • Patent number: 10898716
    Abstract: A method is provided that includes implanting (a) a parenchymal electrode in or in contact with an outer surface of brain parenchyma of a subject identified as at risk of or suffering from a disease, and (b) a cerebrospinal fluid (CSF) electrode in a CSF-filled space of a brain of the subject, the CSF-filled space selected from the group consisting of: a ventricular system and a subarachnoid space. A midplane treatment electrode is disposed in or over a superior sagittal sinus. Control circuitry is activated to drive the parenchymal electrode and the CSF electrode to drive a substance from the brain parenchyma into the CSF-filled space of the brain, and apply a treatment current between the CSF electrode and the midplane treatment electrode to drive the substance from the CSF-filled space of the brain to the superior sagittal sinus. Other embodiments are also described.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: January 26, 2021
    Inventors: Gideon Fostick, Yossi Gross, Alex Tendler